Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0308254 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Balram Rai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostate-Specific Antigen, Early Detection of Cancer, Spatio-Temporal Analysis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, Vetenskapsrådet, Swedish eScience Research Centre.
Abstract (Originalsprache)
Prostate cancer screening using prostate-specific antigen (PSA) testing is controversial but remains prevalent in many countries. There is little information in Sweden or elsewhere on the spatial variation in PSA testing. This study aims to describe the spatio-temporal variation in PSA testing prior to a prostate cancer diagnosis in the Stockholm region at the municipality and small area levels. A population-based register study comprised men aged 40 years and over living in the Stockholm region during 2007–2016. For Stockholm in 2016, we reported the proportion of men who had a PSA test for the preceding one, two, five and ten years by ten-year age groups. The age-standardised proportion of men having a PSA test was reported for municipalities by calendar years. We used spatial smoothing for calculating the age-standardised proportion of men having a PSA test in a small area for each calendar year. In 2016, 74.0% and 77.8% of men aged 60–69 and 70–79 years respectively had taken a PSA test in the previous ten years. The municipalities of Danderyd and Ekerö showed high proportions of PSA testing. A marked heterogeneity in such proportions within each municipality was observed. The odds ratio for having a PSA test for those born in Sweden was 2.22 (95% CI 2.00–2.52). Opportunistic PSA testing is widespread with three quarters of men in their sixties and seventies having had a test in the preceding decade. We found evidence for marked geographical heterogeneity, where more affluent and metropolitan areas had higher levels of testing. Variations in PSA testing was associated with socio-economic position and demographic factors including education, income and country of birth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Department of Sociology and Social Work, Aalborg University, Aalborg Øst, Denmark.
ORCID-Profile: Balram Rai, Rolf Lyneborg Lund
Förderung
- Cancerfonden
- Vetenskapsrådet
- Swedish eScience Research Centre
- Prostatacancerförbundet
- European Commission
Zitieren
APA
Rai, B., Nordström, T., Lantz, A., Lund, R. L., Kuja-Halkola, R., Rado, M., Öberg, S., Hao, S., Du, X., & Clements, M. (2024). Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study. PLOS ONE. https://doi.org/10.1371/journal.pone.0308254
Vancouver
Rai B, Nordström T, Lantz A, Lund RL, Kuja-Halkola R, Rado M, et al. Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study. PLOS ONE. 2024. doi:10.1371/journal.pone.0308254
BibTeX
@article{Rai2024,
author = {Rai, Balram and Nordström, Tobias and Lantz, Anna and Lund, Rolf Lyneborg and Kuja-Halkola, Ralf and Rado, Marta and Öberg, Sara and Hao, Shuang and Du, Xiaoyang and Clements, Mark},
title = {Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0308254}
}
EUVIMED